Displaying 10 out of 11 results

  1. FILE PHOTO: Logo of AstraZeneca is displayed on a screen on the floor at the New York Stock Exchang

    AstraZeneca scores win in race to treat ovarian cancer

    AstraZeneca has made further headway in the race with larger competitor GlaxoSmithKline's to use a promising new class of drugs to treat ovarian ...
  2. The GSK logo is seen on top of GSK Asia House in Singapore

    GSK's ovarian cancer treatment meets main goal in late-stage study

    GlaxoSmithKline said on Monday a late-stage study testing Zejula as a maintenance therapy in patients with first-line ovarian cancer showed ...
  3. Obamacare

    Obamacare led to better cancer outcomes: Studies

  4. New Content Item

    ImmunoGen's ovarian cancer drug fails in late-stage study

  5. New Content Item

    Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study

  6. FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield

    AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies

    British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials.
  7. FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

    AstraZeneca's Lynparza shown to put brakes on ovarian cancer

    An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase ...
  8. New Content Item

    Johnson & Johnson ordered to pay US$417m in cancer lawsuit

  9. New Content Item

    NUS researchers identify possible new treatment strategy for ovarian cancer

    The team of scientists from the Cancer Science Institute of Singapore has identified a way to curb the aggressive spread of ovarian cancer.